Skip to main content
You have permission to edit this article.
Q&A: A look at when the COVID-19 vaccine can be expected
spotlight AP

Q&A: A look at when the COVID-19 vaccine can be expected

  • Updated
  • 0

Sergio Vazquez, left, Dinah Amante and Alex Dolgoter work in a lab at Inovio Pharmaceuticals, a biotech company in San Diego that is developing a COVID-19 vaccine.

The federal government has told states to be ready to distribute doses of a coronavirus vaccine by Nov. 1 — two days before the election. The move raises major questions we can’t answer yet. Is President Donald Trump exerting political pressure to make good on his promise of a vaccine “before the end of the year, or maybe even sooner”?

Is it possible to bring vaccines to market that quickly without leaving doubts about safety and effectiveness that will discourage their use?

Here are some facts to help make sense of the situation.


Concerned about COVID-19?

* I understand and agree that registration on or use of this site constitutes agreement to its user agreement and privacy policy.

Related to this story

Get up-to-the-minute news sent straight to your device.


News Alerts

Breaking News